Evaluating Patients for Second-Line Antiretroviral Therapy in India: The Role of Targeted Viral Load Testing (Q42871048)

9 November 2017

title

Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing (English)

1 reference

9 November 2017

Evaluating Patients for Second-Line Antiretroviral Therapy in India: The Role of Targeted Viral Load Testing (English)

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

25 July 2024

1 reference

1 reference

1

Bharat B Rewari

1 reference

9 November 2017

5

Po Lin Chan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20890211

25 July 2024

author name string

Damodar Bachani

2

1 reference

9 November 2017

Sikhamani Rajasekaran

3

1 reference

9 November 2017

Alaka Deshpande

4

1 reference

9 November 2017

Padmini Srikantiah

6

1 reference

9 November 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

9 November 2017

15 December 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20890211

Journal of Acquired Immune Deficiency Syndromes

25 July 2024

published in

1 reference

9 November 2017

volume

55

1 reference

9 November 2017

issue

5

1 reference

9 November 2017

page(s)

610-614

1 reference

Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching

9 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

Monitoring HIV antiretroviral therapy in resource-limited settings: time to avoid costly outcomes

25 July 2024

2

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

25 July 2024

3

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings

25 July 2024

4

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand

25 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa

25 July 2024

6

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda

25 July 2024

7

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy

25 July 2024

8

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings

25 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

HIV viral load monitoring in resource-limited regions: optional or necessary?

25 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics

25 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy

25 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

25 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

25 July 2024

14

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings

25 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

Antiretroviral roll-out: the problem of second-line therapy

25 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/QAI.0B013E3181F43A31

25 July 2024

Identifiers

1 reference

9 November 2017

1 reference